We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$128M
Cap. Flow
+$26.2M
Cap. Flow %
2.17%
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28

Top Buys

Rank Stock Value
1
TME icon
Tencent Music
TME
+$28.3M
2
LEGN icon
Legend Biotech
LEGN
+$20.2M
3
TCOM icon
Trip.com Group
TCOM
+$16M
4
STAA icon
STAAR Surgical
STAA
+$10.7M
5
ZLAB icon
Zai Lab
ZLAB
+$7.74M

Top Sells

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$21.9M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
NIO icon
NIO
NIO
+$10.3M
4
LI icon
Li Auto
LI
+$8.53M
5
BZ icon
Kanzhun
BZ
+$8.18M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Technology 25.51%
3 Communication Services 14.94%
4 Healthcare 9.44%
5 Real Estate 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDIT icon
201
Editas Medicine
EDIT
$399M
$358K 0.03%
40,380
+10,288
+34% +$113K
DLTR icon
202
Dollar Tree
DLTR
$23.1B
$356K 0.03%
2,518
-180
-7% -$26.8K
IMGN
203
DELISTED
Immunogen Inc
IMGN
$356K 0.03%
71,705
+6,577
+10% +$35.7K
MNKD icon
204
MannKind Corp
MNKD
$1.28B
$354K 0.03%
67,201
-32,857
-33% -$135K
SNDX icon
205
Syndax Pharmaceuticals
SNDX
$1.84B
$353K 0.03%
13,863
+3,799
+38% +$88.6K
TVTX icon
206
Travere Therapeutics
TVTX
$5.33B
$352K 0.03%
16,751
+2,606
+18% +$55.2K
CRSP icon
207
CRISPR Therapeutics
CRSP
$4.58B
$351K 0.03%
8,628
+1,515
+21% +$80.4K
ODFL icon
208
Old Dominion Freight Line
ODFL
$48.5B
$350K 0.03%
2,464
-194
-7% -$27.6K
VCYT icon
209
Veracyte
VCYT
$4.52B
$350K 0.03%
14,767
-8,995
-38% -$209K
ELV icon
210
Elevance Health
ELV
$81.9B
$342K 0.03%
666
-75
-10% -$38.1K
BKR icon
211
Baker Hughes
BKR
$56.8B
$338K 0.03%
+11,451
New +$316K
CLDX icon
212
Celldex Therapeutics
CLDX
$2.77B
$335K 0.03%
7,511
-6,767
-47% -$242K
CVS icon
213
CVS Health
CVS
$137B
$334K 0.03%
3,579
-355
-9% -$34.3K
DADA
214
DELISTED
Dada Nexus
DADA
$329K 0.03%
+47,270
New +$248K
SAGE
215
DELISTED
Sage Therapeutics
SAGE
$328K 0.03%
8,588
-2,753
-24% -$105K
CPRT icon
216
Copart
CPRT
$25.9B
$327K 0.03%
10,746
-574
-5% -$17.2K
CEG icon
217
Constellation Energy
CEG
$98B
$324K 0.03%
3,755
-10
-0.3% -$900
ABNB icon
218
Airbnb
ABNB
$83.7B
$323K 0.03%
3,783
-48
-1% -$4.85K
NEE icon
219
NextEra Energy
NEE
$187B
$322K 0.03%
3,847
-132
-3% -$10.7K
WDAY icon
220
Workday
WDAY
$33.4B
$321K 0.03%
1,919
-96
-5% -$15K
VZ icon
221
Verizon
VZ
$194B
$320K 0.03%
8,131
-374
-4% -$14.1K
VRSK icon
222
Verisk Analytics
VRSK
$26.4B
$317K 0.03%
1,795
-118
-6% -$20.7K
GOSS icon
223
Gossamer Bio
GOSS
$66.5M
$315K 0.03%
145,237
+129,468
+821% +$1.07M
LIN icon
224
Linde
LIN
$237B
$313K 0.03%
959
-37
-4% -$11.6K
AGIO icon
225
Agios Pharmaceuticals
AGIO
$2.16B
$312K 0.03%
11,096
+1,756
+19% +$49.5K
7 8
9
10 11

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, E Fund Management held 362 positions worth $1.2B, up 12% from $1.07B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q4 2022 filing shows 28 new, 88 increased, 207 reduced and 28 closed positions. Its largest new stake was Akero Therapeutics: 9,604 shares worth $526K. The largest sale was KE Holdings, an estimated $21.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q4 2022 buy was Akero Therapeutics: 9,604 shares worth $526K.
  • E Fund Management added most to Tencent Music in Q4 2022, an estimated $28.3M increase.
  • E Fund Management's biggest Q4 2022 reduction was KE Holdings, cutting an estimated $21.9M.
  • E Fund Management fully exited Li Auto in Q4 2022, selling an estimated $8.53M.
  • E Fund Management's ten largest holdings make up 57% of its $1.2B portfolio in Q4 2022.
  • E Fund Management opened 28 new positions and closed 28 in Q4 2022.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.2B.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.